Sleep Apnea Clinical Trials 2023

Sleep Apnea Clinical Trials 2023

Sleep Apnea research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in sleep apnea clinical trials today.

Sleep Apnea Clinical Trials

Here are the 6 most popular medical studies for sleep apnea

Popular filter options for sleep apnea trials

Obstructive Sleep Apnea Clinical Trials

View 71 Obstructive Sleep Apnea medical studies.

OSA Clinical Trials

View 71 OSA medical studies.

Sleep Apnea Clinical Trials With No Placebo

View 97 sleep apnea medical studies that do not have a placebo group.

View More Sleep Apnea Trials

See another 76 many medical studies focused on sleep apnea.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to sleep apnea

What are the top hospitals conducting sleep apnea research?

Sleep apnea, a common yet potentially serious sleep disorder, is being tackled head-on by some of the top hospitals in various locations. In Detroit, the John D. Dingell VA Medical Center has taken up the challenge with four ongoing sleep apnea trials. While it may be relatively new to this area of research, having just initiated its first trial in 2021, their commitment to finding solutions for sleep apnea is highly commendable. Similarly, Brigham and Women's Hospital in Boston has also dedicated itself to combating this condition through four active trials. With their first recorded sleep apnea trial dating back to 2019, they have been at the forefront of research and innovation.

North of the border in Toronto lies Sunnybrook Health Sciences Centre—although they haven't conducted any previous clinical trials on sleep apnea as yet—this institution is currently involved in three ongoing studies regarding this sleep disorder. This emerging focus holds tremendous potential for advancements that could benefit patients worldwide.

In Tucson at the University of Arizona, researchers have been investigating sleep apnea since 2008 when they undertook their inaugural study on this topic. Since then, they have accumulated valuable insights from two completed trials and continue furthering their efforts with three active investigations today.

Meanwhile in sunny San Diego at the University of Californiaf Arizona, researchers have been investigating sleep apnea since 2008 when they undertook their inaugural study on this topic. Since then, they have accumulated valuable insights from two completed trials and continue furthering their efforts with three active investigations today.

Meanwhile in sunny San Diego at the University of California San Diego (UCSD), experts are delving into understanding and managing sleep apnea as well; although UCSD's involvement started more recently recorded only two years ago but already contributing significantly by conducting one all-time trial alongside current addressing projects numbering two.

These esteemed institutions spearhead pioneering research endeavors across different regions while aiming towards improving our understanding and treatment options for individuals grappling with this pervasive condition that affects quality of life during waking hours due to disrupted restful nights' slumber . By pushing boundaries and collaborating closely within these clinical settings , there remains hope that breakthroughs will ultimately lead us towards better management strategies thus ensuring improved health outcomes for sleep apnea patients globally.

Which are the best cities for sleep apnea clinical trials?

La Jolla, California, Toronto, Ontario, Philadelphia, Pennsylvania, Detroit, Michigan and Boston Massachusetts, Pennsylvania, Detroit, Michigan and Boston Massachusetts are among the best cities for sleep apnea clinical trials. La Jolla leads with 10 active trials focusing on treatments such as Acetazolamide, Supplemental Oxygen and Continuous Positive Airway Pressure (CPAP). Toronto follows closely behind with 8 ongoing studies evaluating Home Sleep Apnea Tests and CPAP therapy. Philadelphia also has 8 active trials investigating interventions like CPAP and Drug-Induced Sleep Endoscopy. Similarly, Detroit's 8 active trials explore treatments including CPAP and supplemental oxygen. Lastly, Boston offers 8 studies covering a range of interventions like Oxybutynin and the Genio™ system. These cities provide valuable opportunities for individuals with sleep apnea to participate in research that could lead to improved care options in the future.

Which are the top treatments for sleep apnea being explored in clinical trials?

Clinical trials are shedding light on the top treatments for sleep apnea, with acetazolamide emerging as a promising contender. Currently involved in three active trials dedicated to sleep apnea research, this drug has also been featured in two previous studies since its initial listing in 2008. As researchers delve deeper into finding effective solutions for this common sleep disorder, acetazolamide shows potential in addressing the challenges faced by individuals suffering from sleep apnea. With further exploration and development, it could bring much-needed relief to those affected by this condition.

What are the most recent clinical trials for sleep apnea?

Recent clinical trials for sleep apnea offer promising advancements in the field. Oxygen plus supportive care (OXT) has shown potential benefits for patients with sleep apnea, with Phase 2 trials becoming available on 9/27/2023. Additionally, Atomoxetine-plus-Oxybutynin (AtoOxy) and Acetazolamide/Eszopiclone have exhibited positive results in Phase 1 and Phase 2 studies conducted as of September 2023. Another notable trial is Ato-oxy, which reached Phase 2 availability on 8/1/2023. Furthermore, a health communication message intervention study focusing on sleep apnea has progressed to Phases 1 and 2 since June 2023. These recent developments provide hope for improved treatment options and greater understanding of this complex condition affecting many individuals worldwide.

What sleep apnea clinical trials were recently completed?

Recently, there have been several notable clinical trials focused on sleep apnea that have reached completion. These studies represent significant advancements in the field and provide valuable insights into potential treatment options.